Abstract: Sparse arrays have gained increasing research attention due to their potential to reduce system cost and weight. However, current studies on sparse array synthesis often overlook the ...

We have made significant progress towards building foundational video diffusion models. As these models are trained using large-scale unsupervised data, it has become crucial to adapt these models to ...

Abstract: Variational approaches to disparity estimation typically use a linearised brightness constancy constraint, which only applies in smooth regions and over small distances. Accordingly, current ...

Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...